“FDA Agrees to New Trials for Ecstasy as Relief for PTSD Patients”

0
294

Last week, the FDA gave permission for ecstasy to move into Phase 3 clinical trials for the treatment of PTSD. “If they can keep getting good results, it will be of great use. PTSD can be very hard to treat. Our best therapies right now don’t help 30 to 40 percent of people. So we need more options.”

Article →­

ecstasy-for-ptsd

LEAVE A REPLY